nmn 제조업체에 대한 간략한 소개를 제공합니다 | 본탁

일반적으로 증권 시세 표시기 분말은 일반적으로 화학적 또는 효소 합성 또는 발효 생합성을 통해 생산됩니다. 세 가지 방법 모두 장단점이 있습니다.
Chemical synthesis is expensive and labor intensive, and all raw ingredients used are categorized as “unnatural,” i.e., not from biological systems. There are, however, some advantages from the manufacturer’s perspective. The yield is well suited to mass 증권 시세 표시기 powder production, and all of those unnatural raw ingredients can be carefully controlled. But there are a number of drawbacks as well. Some of the solvents used in the manufacturing process are seriously bad from an environmental standpoint, and impurities and by-products can be challenging to remove from the finished product – that’s seriously bad for the consumer.
Enzymatic production of 증권 시세 표시기 powder, on the other hand, is considered a “green preparation method.” Like the chemical route, it’s pricey, but it offers a higher yield and impressively high purity. The finished 증권 시세 표시기 ticks all the boxes – stable, easily absorbed, lightweight, low density, and a low molecular structure.
발효는 증권 시세 표시기을 생산하는 방법으로 연구되어 왔지만, 수율은 고품질임에도 불구하고 매우 형편없기 때문에 많은 보충제 회사들은 매우 현명하게 더 효율적인 다른 공정을 찾고 있습니다.

1、“Bonzyme”Whole-enzymatic method, environmental-friendly, no harmful solvent residues manufacturing powder 
2、Exclusive“Bonpure”seven-step purification technology, high purity（up to 99.9%) and stability of production of 증권 시세 표시기 powder 
3, 산업 선도 기술 : 15 개의 국내 및 국제 증권 시세 표시기 특허
4, 자체 소유 공장 및 증권 시세 표시기 분말 제품의 고품질 및 안정적인 공급을 보장하기 위해 여러 국제 인증을 획득했습니다.  
5, 여러 생체 내 연구에 따르면 Bontac 증권 시세 표시기 분말은 안전하고 효과적입니다.
6, 원스톱 제품 솔루션 사용자 정의 서비스 제공
7, 하버드 대학의 유명한 데이비드 싱클레어 팀의 증권 시세 표시기 원료 공급 업체.

According to recent industrial report, only several products from worldwide 증권 시세 표시기 manufacturers came close to meeting label claim and contain not enough 증권 시세 표시기. Almost products performed better, having at least 88% of the label claim up to small overages. A lone 250 mg product was identified as BRL. In sum, ChromaDex said that 64% of the products tested contained less than 1% of the stated amount of the active ingredient. which should give consumers pause. While this is a limited snapshot of the vast 증권 시세 표시기 finished product landscape. it does provide a glimpse into the high variability   of product quality that is available. The majority of the products may purchase online contain such a small amount of 증권 시세 표시기 that there would be no clinical benefits achieved from the dose. Another concern with these adulterated products is that the actual contents are not known and could pose a risk to the user the company said in a statement.